Population-average effect of ocular copathology, feature or intraoperative complication on the error of expected refractive outcome, reported as compound numbers: sphere cylinder axis
| Posterior mean | 95% credible interval | |
| Women aged 77 years with no copathology nor complications* | −0.30/0.45×4 | −0.32/0.46×5 to –0.29/0.45×4 |
| Men | +0.12/0.051×91 | +0.11/0.05×88 to +0.13/0.051×93 |
| Age (per 10 years) | −0.0094/0.06×97 | −0.012/0.06×96 to −0.0065/0.06×98 |
| Diabetic retinopathy | +0.082/0.03×104 | +0.070/0.03×96 to +0.093/0.04×110 |
| Pseudoexfoliation/phacodonesis | +0.065/0.01×158 | +0.036/0.01×23 to +0.086/0.03×145 |
| Previous vitrectomy surgery | −0.039/0.03×66 | −0.069/0.04×59 to −0.011/0.02×82 |
| High myopia | −0.066/0.03×57 | −0.085/0.04×55 to −0.047/0.02×62 |
| Glaucoma | −0.099/0.05×95 | −0.11/0.05×91 to −0.089/0.05×99 |
| Posterior capsular rupture | −0.38/0.04×72 | −0.42/0.05×64 to −0.35/0.03×88 |
| Uveitis/synaechiae | −0.029/0.03×16 | −0.071/0.05×28 to +0.0075/0.03×175 |
| Previous trabeculectomy surgery | −0.076/0.07×113 | −0.11/0.06×100 to −0.041/0.09×120 |
| Other retinal pathology | −0.00074/0.03×77 | −0.037/0.04×64 to +0.030/0.02×101 |
| Brunescent/white mature cataract | +0.0026/0.01×69 | −0.016/0.02×59 to +0.020/0.01×90 |
| Time period | ||
| Within 3 months† | – | – |
| Between 3 and 6 months | +0.062/0.03×160 | +0.053/0.03×166 to +0.070/0.04×156 |
| Between 6 and 12 months | +0.083/0.03×163 | +0.071/0.03×171 to +0.094/0.04×158 |
| More than 12 months | +0.12/0.05×172 | +0.11/0.05×178 to +0.14/0.06×167 |
| Refraction type | ||
| Subjective† | – | – |
| Autorefractive | −0.062/0.05×19 | −0.072/0.06×21 to −0.052/0.05×16 |
| Focimetry | +0.019/0.00×180 | +0.002/0.01×40 to +0.028/0.01×142 |
| Focimetry (second pair glasses) | +0.00024/0.04×26 | −0.064/0.07×35 to +0.057/0.03×180 |
| Other | −0.15/0.04×161 | −0.19/0.03×5 to −0.12/0.06×150 |
*Reference patient (woman aged 77 years with a subjective refraction observed within 3 months of operation).
†Reference category of that variable.